Washington Homeopathic Recalls Cell Salts Combination 6X Tablets for CGMP Deviations
Washington Homeopathic Products, Inc. is recalling Cell Salts Combination 6X Tablets because they were not manufactured under current good manufacturing practices.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, which typically indicates a violation that may cause temporary or medically reversible health consequences, fitting the Moderate severity criteria.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Cell Salts Combination 6X Tablets, 300-count bottles, 30g. The product was manufactured in India exclusively for Washington Homeopathic Products, Inc. The recall involves 829 bottles with lot numbers BC18C142 and BC18G056.
The recall was initiated because the products were not manufactured under current good manufacturing practices (CGMP). This is a Class II recall, which indicates a violation of CGMP that may cause temporary or medically reversible health consequences.
The product was distributed nationwide throughout the United States, Canada, and Saudi Arabia. Consumers should stop using the product and contact Washington Homeopathic Products, Inc. for further instructions.
The recalled product
- Product
- Cell Salts Combination 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64200 9.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 829
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: BC18C142 and BC18G056
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateSyphilinum homeopathic drug recalled for manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
- ModerateStreptococcinum Homeopathic Drug Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
- ModerateHumulus 6X, 15X Homeopathic Pills Recalled for Failed Testing
FDA (Drugs) · 2021-10-06
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModerateWockhardt Recalls Captopril Tablets Due to CGMP Deviations
FDA (Drugs) · 2015-07-29